Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1Genitourinary 1Breast 1

Conditions

Prostatic Neoplasms 1Lymphoma, Non-Hodgkin 1Hodgkin Disease 1Breast Neoplasms 1

Interventions

Paclitaxel 291Gemcitabine 254Carboplatin 253Cisplatin 250Radiotherapy 219Cyclophosphamide 218Irinotecan 184pembrolizumab 180Docetaxel 174Bevacizumab 166Capecitabine 148Nivolumab 141Fluorouracil 132Dexamethasone 125Bortezomib 123Oxaliplatin 115Cytarabine 113Erlotinib Hydrochloride 112Temozolomide 110Sorafenib 110Doxorubicin 106Rituximab 105Leucovorin 105Etoposide 105Filgrastim 99Everolimus 97Lenalidomide 95Ipilimumab 90Pemetrexed 89fludarabine phosphate 84

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Completed × Tomography, Emission-Computed, Single-Photon × Clear all
NCT04746638 2023-11-28

Molecular Imaging of Gastrin Releasing Peptide Receptors Using Labeled Technetium-99m RM26

Tomsk National Research Medical Center of the Russian Academy of Sciences

Phase 1 Completed
10 enrolled
BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT04292626 2021-04-01

Molecular Imaging of Lymphoma Using Labeled Technetium-99m 1-Thio-D-Glucose

Tomsk National Research Medical Center of the Russian Academy of Sciences

Phase 1 Completed
16 enrolled
Lymphoid

Hodgkin Disease, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡